PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53
Thomas Grellety(Inserm), Antoîne Italiano(Université de Bordeaux)
Cited by 33
Related Papers
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial
|Clinical Cancer Research|2021|152
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors
|BMC Cancer|2012|62
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics
|Molecular Cancer|2024|28
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis
|npj Precision Oncology|2024|13
Antitumor Effects of PRMT5 Inhibition in Sarcomas
|Cancer Research Communications|2023|3